Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White,...
Never have we seen CLSD cross on the weekly RSI to oversold. CLSD made new lows. The more I look at it, the more this looks like a possible bottom as the big picture shows a possible 5th elliot wave + if a possible wyckoff spring. Buy when there is blood on the streets? 2 year hold?
CLSD, set buy limit order with other cancels other for target/stop, still learning.
Position size: 500 shares worth $3,250
Buy Limit Order: 6.5
Sell Limit Order: 7.5
Stop Loss: 6.0
Time Frame: October 15th